Physiologic Pacing Registry

NCT ID: NCT03719040

Last Updated: 2024-08-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

870 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-27

Study Completion Date

2021-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Physiologic Pacing Registry is a prospective, observational, multi-center registry performed to gain a broader understanding of 1) physiologic pacing implant and follow-up workflows, including pacing and sensing measurements and 2) the clinical utility in creating a 3-dimensional electro-anatomical map of cardiac structures prior to physiologic pacing device implants based on the clinical site's routine care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Physiologic Pacing Registry will be conducted to gain a deeper understanding of physiologic pacing device implants and follow-up workflows, including device and programmer measurements to help inform Abbott's product and clinical data development efforts. Additionally, the registry will provide a broader understanding of the clinical utility in mapping physiologic pacing structures with the use of Abbott's EnSite Cardiac Mapping System with an electrophysiology catheter prior to device implants for those institutions where mapping is routine care prior to physiologic pacing device implant.

The registry will include patients undergoing implantation of an Abbott pacemaker, defibrillator, or a cardiac resynchronization therapy (CRT) pacemaker (CRT-P) or CRT defibrillator (CRT-D) according to the clinical site's routine care. Only patients scheduled to receive an Abbott device may be enrolled to ensure proper device data collection for future software and other physiologic pacing product development. The decision to provide physiologic pacing therapy and selection of devices for implant are at the discretion of the implanting physician. Abbott will collect data on the use of all commercially available leads and associated implant tools based on the physician's discretion as part of routine clinical practice within the registry.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bradycardia Sinus Node Dysfunction Heart Block Syncope Cardiomyopathies Ventricular Tachycardia Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physiologic pacing device implant

An alternative and potentially more effective pacing strategy for patients with electrical conduction abnormalities is physiologic pacing. Physiologic pacing is achieved by delivering a pacing stimulus to a cardiac conduction structure, such as the bundle of His or left bundle branch (LBB) of the His-Purkinje system, with a permanent lead. Physiologic pacing activates the heart through the native His-Purkinje conduction system, thus offering the most physiologic pacing approach to correct electrical dyssynchrony. Physiologic pacing has emerged as a feasible and safe alternative to pacemaker therapy and CRT with clinical and electrophysiological advantages.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Scheduled for implantation of an Abbott pacemaker, defibrillator, or CRT-P/D device with any commercially available pacing lead as part of a physiologic pacing procedure according to the clinical site's routine care.
2. At least 18 years of age.
3. Willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
4. Provided written informed consent prior to any registry-related procedures.

Exclusion Criteria

1. History of tricuspid valve repair or replacement.
2. Currently participating in another clinical study with an active treatment arm and belong to the active arm
3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results.
4. Chronic physiologic pacing lead implanted
5. Life expectancy of \< 6 months.
6. Known contraindication for physiologic pacing therapy/implant (i.e. ongoing infection, known occlusion of the subclavian vein, etc.).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kwangdeok Lee

Role: STUDY_DIRECTOR

Abbott

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Heart Center Research, LLC.

Huntsville, Alabama, United States

Site Status

Mills-Peninsula Medical Center

Burlingame, California, United States

Site Status

University of California at San Diego (UCSD) Medical Center

San Diego, California, United States

Site Status

Yoel R. Vivas, MD

Delray Beach, Florida, United States

Site Status

Usman R. Siddiqui, MD

Winter Park, Florida, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

University of Chicago

Chicago, Illinois, United States

Site Status

IU Health Bloomington Hospital

Bloomington, Indiana, United States

Site Status

Iowa Heart Center

West Des Moines, Iowa, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Charlton Memorial Hospital

Fall River, Massachusetts, United States

Site Status

Providence Hospital

Southfield, Michigan, United States

Site Status

The Valley Hospital

Ridgewood, New Jersey, United States

Site Status

New Mexico Heart Institute

Albuquerque, New Mexico, United States

Site Status

New York University Hospital

New York, New York, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Providence Heart & Vascular Institute

Portland, Oregon, United States

Site Status

Geisinger Medical Center

Danville, Pennsylvania, United States

Site Status

Pinnacle Health System

Harrisburg, Pennsylvania, United States

Site Status

Lancaster General Hospital

Lancaster, Pennsylvania, United States

Site Status

Allegheny General Hospital - ASRI

Pittsburgh, Pennsylvania, United States

Site Status

Donald Guthrie Foundation for Education and Research

Sayre, Pennsylvania, United States

Site Status

Texas Cardiac Arrhythmia

Austin, Texas, United States

Site Status

The Methodist Hospital

Houston, Texas, United States

Site Status

University of Vermont College of Medicine

Burlington, Vermont, United States

Site Status

St. Joseph Medical Center

Tacoma, Washington, United States

Site Status

The Northern Hospital

Epping, Victoria, Australia

Site Status

Mulgrave Private Hospital

Mulgrave, Victoria, Australia

Site Status

Fiona Stanley Hospital

Murdoch, Western Australia, Australia

Site Status

Universitätsklinik Graz

Graz, Styria, Austria

Site Status

QE II Health Sciences

Halifax, Nova Scotia, Canada

Site Status

CHUS Fleurimont

Sherbrooke, Styria, Canada

Site Status

Fakultni nemocnice Kralovske Vinohrady

Prague, Central Bohemia, Czechia

Site Status

CHRU Rouen Hospital Charles Nicolle

Rouen, Upper Normandy, France

Site Status

Clinique Ambroise Pare

Neuilly-sur-Seine, Île-de-France Region, France

Site Status

Herzzentrum Leipzig GmbH

Leipzig, Saxony, Germany

Site Status

Herz-und Diabetes Zentrum NRW

Bad Oeynhausen, , Germany

Site Status

Prince of Wales Hospital

Hong Kong, Hong Kong SAR, Hong Kong

Site Status

Fortis Memorial Research Institute

Gurugramam, Haryana, India

Site Status

Asian Institute of Gastroenterology (AIG) Hospital

Hyderabad, , India

Site Status

Ospedale Generale Regionale F. Miulli

Acquaviva delle Fonti, , Italy

Site Status

Ospedale S.Maria della Misericordia

Rovigo, , Italy

Site Status

Maastricht University Medical Center

Maastricht, , Netherlands

Site Status

Gornoslaskie Centrum Medyczne im.prof. Leszka Gieca

Katowice, , Poland

Site Status

National Heart Centre Singapore

Singapore, Central, Singapore

Site Status

NG Teng Fong General Hospital

Singapore, Central, Singapore

Site Status

Christiaan Barnard Memorial Hospital

Cape Town, , South Africa

Site Status

Hospital Universitario Virgen de la Nieves

Granada, , Spain

Site Status

Hospital General Juan Ramon Jimenez

Huelva, , Spain

Site Status

Center Inselspital Bern

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Canada Czechia France Germany Hong Kong India Italy Netherlands Poland Singapore South Africa Spain Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Vazquez PM, Mohamed U, Zanon F, Lustgarten DL, Atwater B, Whinnett ZI, Curila K, Dinerman J, Molina-Lerma M, Wiley J, Grammatico A, Lee K, Vijayaraman P. Result of the Physiologic Pacing Registry, an international multicenter prospective observational study of conduction system pacing. Heart Rhythm. 2023 Dec;20(12):1617-1625. doi: 10.1016/j.hrthm.2023.06.006. Epub 2023 Jun 20.

Reference Type DERIVED
PMID: 37348800 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ABT-CIP-10270

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Minimizing Ventricular Pacing
NCT01611389 UNKNOWN NA
EP Device Registry
NCT04460209 RECRUITING
Allometric-Pace Study
NCT05766462 COMPLETED
Ventricular Pace Suppression Study
NCT01053832 COMPLETED NA